These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4336006)

  • 1. [Experimental testing of some piperidine propanol diastereomers in animals as potential parkinsonism drugs].
    Oelszner W; Walther H; Wagner U
    Acta Biol Med Ger; 1971; 26(5):1061-70. PubMed ID: 4336006
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antimuscarinic action of parkinsonism drugs on peripheral structures and correlation with central efficacy or clinical dosage].
    Oelszner W; Walther H; Wagner U
    Acta Biol Med Ger; 1971; 26(5):1045-59. PubMed ID: 5145608
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug research on norbornan derivatives. 2].
    Krieger H
    Arzneimittelforschung; 1968 Mar; 18(3):324-30. PubMed ID: 4387156
    [No Abstract]   [Full Text] [Related]  

  • 4. Differences in the stereospecificity of closely related compounds; a reinvestigation of the enantiomers of procyclidine, benzhexol and their metho- and etho-salts.
    Barlow RB
    J Pharm Pharmacol; 1971 Feb; 23(2):90-7. PubMed ID: 4396885
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tremaril--a new antiparkinsonian drug].
    Naess K
    Tidsskr Nor Laegeforen; 1969 Aug; 89(16):1276-7. PubMed ID: 5375358
    [No Abstract]   [Full Text] [Related]  

  • 6. Central and peripheral anticholinergic potency of some drugs antagonistic to anticholinesterase poisoning.
    Madill HD; Stewart WC; Savoie ML
    Can J Physiol Pharmacol; 1968 Jul; 46(4):559-65. PubMed ID: 5668200
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of elantrine, a new anti-Parkinsonism agent, on drug-induced tremor in mice.
    Ursillo RC; McCulloch JA
    Arch Int Pharmacodyn Ther; 1972 May; 197(1):132-40. PubMed ID: 5031571
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of various cholinolytics on experimental catatonia].
    Mashkovskii MD; Zaitseva KA
    Biull Eksp Biol Med; 1967 Aug; 64(8):54-6. PubMed ID: 5630324
    [No Abstract]   [Full Text] [Related]  

  • 9. [Summarizing description of the pharmacology of budipine, a new 4,4-diphenylpiperidine derivative used in Parkinson therapy (author's transl)].
    Menge HG; Brand U
    Arzneimittelforschung; 1982; 32(2):85-98. PubMed ID: 7199925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation of antitremorine activity and clinical antiparkinsonian effect. A clinical trial of AGN 511 in postencephalitic parkinsonism.
    Mattila MJ; Spiers AS; Sharkey J; Laurence DR
    Arzneimittelforschung; 1970 Dec; 20(12):1888-9. PubMed ID: 5537091
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of parkinsonism with the Bulgarian preparations INHA-17 and bellazon].
    Stoliarova LG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(5):698-703. PubMed ID: 4873628
    [No Abstract]   [Full Text] [Related]  

  • 12. Central and peripheral nervous effects of atropine sulfate and mepiperphenidol bromide (darstine) on human subjects.
    WHITE RP; RINALDI F; HIMWICH HE
    J Appl Physiol; 1956 May; 8(6):635-42. PubMed ID: 13331850
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experiences with the use of 1-nortricyclenyl-1-phenyl-3-piperidino-1-propanol HC1 (isomer mixture)--P 259--VEB Fahlberg List Magdeburg in the treatment of severe disorders of the extrapyramidal motor system].
    Lange E; Seidel K; Niedermeyer K; Poppe W
    Dtsch Gesundheitsw; 1966 Feb; 21(8):380-3. PubMed ID: 5968216
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preliminary tests with injectable biperiden in the treatment of neurodysleptic crises induced by neuroleptic drugs].
    Madalena JC
    Hospital (Rio J); 1969 Aug; 76(2):497-500. PubMed ID: 5307639
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
    Klett CJ; Caffey E
    Arch Gen Psychiatry; 1972 Apr; 26(4):374-9. PubMed ID: 4552131
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of crampus syndrome using Akineton].
    Bredl W
    Med Welt; 1968 Aug; 31():1712-4. PubMed ID: 5718211
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study of a synthetic anti-parkinsonian drug, akinophyl (or 2-piperidino-1-phenyl-bicycloheptenyl-propanol chlorhydrate)].
    Haumonté MT; Lefèvre E; Wurtz
    Ann Med Psychol (Paris); 1969 Mar; 1(3):444-50. PubMed ID: 5376738
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of physostigmine and tetrabenazine on spinal motor control and its inhibition by drugs which influence reserpine rigidity.
    Jurna I; Theres C; Bachmann T
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(3):427-38. PubMed ID: 4239718
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drugs with an effect on the transmission of stimuli in the peripheral nervous system].
    Haller R
    Mitt Dtsch Pharm Ges Pharm Ges DDR; 1968 Apr; 38(4):73-84. PubMed ID: 4299580
    [No Abstract]   [Full Text] [Related]  

  • 20. Reserpine rigidity in the rat--a model for the analysis of antiparkinson drugs.
    Jurna I
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 259(2):181. PubMed ID: 4232669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.